Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
BEFREE |
KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications.
|
20049644 |
2010 |
Colorectal Neoplasms
|
0.500 |
CausalMutation
|
group |
CLINVAR |
Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma.
|
19794125 |
2009 |
Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
LHGDN |
BRAF mutation is associated with the CpG island methylator phenotype in colorectal cancer from young patients.
|
18778891 |
2009 |
Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Significantly, systemically administered rIGFBP7 blocks the growth of colorectal tumors containing an activating RAS or BRAF mutation in mouse xenografts.
|
19861408 |
2009 |
Colorectal Neoplasms
|
0.500 |
CausalMutation
|
group |
CLINVAR |
Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma.
|
19363522 |
2009 |
Colorectal Neoplasms
|
0.500 |
CausalMutation
|
group |
CLINVAR |
Clinical biomarkers in oncology: focus on colorectal cancer.
|
19537845 |
2009 |
Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Secondly, considering the alternative possibility, we identified genes whose DNA hypermethylation was closely linked to BRAF(V600E) and CIMP in 235 primary colorectal tumors.
|
20027224 |
2009 |
Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors.
|
19213871 |
2009 |
Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
LHGDN |
Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer.
|
18757341 |
2008 |
Colorectal Neoplasms
|
0.500 |
Biomarker
|
group |
CTD_human |
Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study.
|
18718023 |
2008 |
Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
LHGDN |
BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations.
|
18098337 |
2008 |
Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
LHGDN |
Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype.
|
18628431 |
2008 |
Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
LHGDN |
Colorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM.
|
18806830 |
2008 |
Colorectal Neoplasms
|
0.500 |
CausalMutation
|
group |
CLINVAR |
Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD).
|
18186519 |
2008 |
Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
LHGDN |
Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study.
|
18718023 |
2008 |
Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
LHGDN |
Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer.
|
18435933 |
2008 |
Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
LHGDN |
Clinicopathologic characteristics, CpG island methylator phenotype, and BRAF mutations in microsatellite-stable colorectal cancers without chromosomal instability.
|
18517279 |
2008 |
Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
LHGDN |
Prevalence of mutations in APC, CTNNB1, and BRAF in Tunisian patients with sporadic colorectal cancer.
|
18992635 |
2008 |
Colorectal Neoplasms
|
0.500 |
CausalMutation
|
group |
CLINVAR |
Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.
|
19001320 |
2008 |
Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Rac1b overexpression and B-Raf(V600E) are significantly associated in primary colorectal tumors (P = .008) and colorectal cell lines.
|
18602919 |
2008 |
Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
LHGDN |
CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.
|
18834226 |
2008 |
Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
LHGDN |
Relationship of BRAF mutation, morphology, and apoptosis in early colorectal cancer.
|
17924122 |
2008 |
Colorectal Neoplasms
|
0.500 |
Biomarker
|
group |
LHGDN |
Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.
|
19001320 |
2008 |
Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
LHGDN |
Role of the BRAF mutations in the microsatellite instability genetic pathway in sporadic colorectal cancer.
|
17195912 |
2007 |
Colorectal Neoplasms
|
0.500 |
GeneticVariation
|
group |
LHGDN |
KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression.
|
16953233 |
2007 |